The Food and Drug Administration on Wednesday granted an emergency use authorization to Pfizer and BioNTech’s Covid-19 vaccine booster, though for now the FDA said use of the booster should be restricted to people over the age of 65, adults 18 and older at high risk of severe Covid, and […]
Read More
A programme of COVID booster vaccinations will begin next week, England’s Health Secretary Sajid Javid has confirmed. A similar plans were announced for Scotland, Wales, and Northern Ireland. People aged 50 and over, younger people with certain health conditions, and frontline health and social care workers will be offered a further jab. […]
Read More
A US Food and Drug Administration (FDA) advisory panel voted unanimously today to recommend a booster dose of Pfizer’s mRNA COVID-19 vaccine for those 65 and older, and for those at high risk of severe outcomes from the disease, including healthcare workers. This followed an earlier 16-2 vote by the […]
Read More
Risk of severe disease drops by factor of almost 20 in people over 60 — but some dispute the benefits of offering a third dose. Older Israelis who have received a third dose of a COVID-19 vaccine are much less likely to test positive for SARS-CoV-2 or to develop severe […]
Read More